Let's focus on what we can do!

By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • 65% of Patients Discontinue Therapy Baclofen Within a Year in Study – Multiple Sclerosis News Today

65% of Patients Discontinue Therapy Baclofen Within a Year in Study – Multiple Sclerosis News Today

Tuesday, 24 January, 2023

65% of Patients Discontinue Therapy Baclofen Within a Year in Study – Multiple Sclerosis News Today

About 10%-20% of people with multiple sclerosis (MS) receive baclofen to control their spasticity, but up to half of patients stop the medication in the first six months, a large Swedish population-based study shows.

The high rates of discontinuation suggest baclofen has “a low success rate of treating spasticity and demonstrates an unmet need of tolerated, effective spasticity treatments,” researchers wrote.

The study, “Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study,” was published in the Journal of Neurology, Neurosurgery & Psychiatry.

Read more at: https://multiplesclerosisnewstoday.com/more-than-half-ms-patients-discontinue-baclofen-study/

Categories :
  • Latest Headlines
  • Multiple Sclerosis
Socials :

Recent posts